Skip to main content
SpringerLink
Log in

IV-to-oral ofloxacin switch programme cost saving

  • Newsletter Article
  • Published:
PharmacoEconomics & Outcomes News Weekly

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

IV-to-oral ofloxacin switch programme cost saving. Pharmacoecon. Outcomes News 232, 8 (1999). https://doi.org/10.1007/BF03275150

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03275150

Keywords

Search

Navigation